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Definition 
(Bronchial) Asthma is defined as a chronic 
inflammatory disorder of the airways which 
characterized by bronchial hyper-responsiveness and 
variable airflow obstruction, that is often reversible 
either spontaneously or with treatment, and 
manifests itself as recurrent episodes of wheezing, 
breathlessness, chest tightness and cough, that may 
occur a few times a day or a few times per week and 
depending on the person may become worse at night 
or with exercise. 
https://en.wikipedia.org/wiki/Asthma ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
USMLE TEST 
A child accidentally aspirates a small pebble that lodges in the 
lower portion of the right inferior lobe. A radiograph is shown 
in Figure A. What changes are expected to occur in the 
arterial blood supply for this portion of the lung?  
1.  Increased, secondary to arterial vasodilation  
2.  Increased, secondary to active hyperemia  
3.  No change, due to autoregulation  
4.  Decreased, secondary to arterial vasoconstriction  
5.  Decreased, secondary to a decrease in surfactant 
synthesis  
 https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4: The clinical presentation is consistent for 
an aspirated object. As a result arterial blood supply for this 
portion of the lung will decrease due to arterial vasoconstriction. 
Incorrect answers: 
1: As described above, local alveolar hypoxia causes 
vasoconstriction, not vasodilation in the lung, 2: Active hyperemia 
refers to an increase in blood flow secondary to the accumulation 
of metabolic byproducts. Active hyperemia is not a response that 
alters blood flow in the lung, 3: Unlike the kidney, heart, and brain, 
autoregulation does not influence the flow of blood in the lung, 5: 
Surfactant, synthesized by type II pneumocytes, reduces surface 
tension in the lung and is not a major factor in blood flow 
regulation.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Global Initiative for Asthma (GINA)   
In 1992, WHO and the US-based National Heart, Lung 
and Blood Institute jointly formed GINA to cut deaths 
and disability by developing and implementing an 
optimal strategy for asthma management and 
prevention.  
GINA's goal is to build an active network with multiple 
organizations concerned with asthma to ensure better 
patient care world-wide. 
http://www.who.int/mediacentre/factsheets/fs206/en/ 
Epidemiology   
• There are about 315 million people estimated to be 
suffering from asthma worldwide 
• The global prevalence of asthma, using a definition 
of clinical asthma or treated asthma, is estimated to 
be about 4.5%  
• Using a less rigorous definition for diagnosis of 
asthma, the global prevalence is approximately 
8.6%  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
Epidemiology 
http://www.nature.com/nri/journal/v6/n11/images/nri1958-f3.jpg 
Epidemiology 
http://image.slidesharecdn.com/ginamodified-090721100743-phpapp02/95/gina-global-initiative-against-asthma-14-728.jpg?cb=1248170947 
Risk Factors and Etiology     
• Asthma is caused by a combination of complex and 
incompletely understood environmental and genetic 
interactions 
• These factors influence both asthma severity and asthma 
responsiveness to treatment 
• Onset before age 12 is more likely due to genetic influence, 
while onset after 12 is more likely due to environmental 
influence. 
 
https://en.wikipedia.org/wiki/Asthma#Causes 
Risk Factors and Etiology          
Environmental    
https://en.wikipedia.org/wiki/Asthma#Causes 
• Smoking during pregnancy and after delivery 
• Low air quality 
• Exposure to indoor volatile organic compounds 
(formaldehyde, phthalates, etc.)  
• There is an association between paracetamol use and 
asthma   
• Exposure to indoor allergens (dust mites, cockroaches, 
animal dander, and mold.)  
• Certain viral respiratory infections (respiratory syncytial 
virus and rhinovirus) 
• Certain other infections, however, may decrease the risk. 
 
Risk Factors and Etiology                
Hygiene Hypothesis    
https://en.wikipedia.org/wiki/Asthma#Causes 
• The increased rates of asthma is a direct and 
unintended result of reduced exposure, during 
childhood, to non-pathogenic bacteria and viruses 
• Exposure to bacterial endotoxin in early childhood 
may prevent the development of asthma  
• Use of antibiotics in early life has been linked to the 
development of asthma 
• Delivery via caesarean section is associated with an 
increased risk (estimated at 20–80%) of asthma.  
 
Risk Factors and Etiology                
Genetic   
https://en.wikipedia.org/wiki/Asthma#Causes 
• Family history is a risk factor for asthma, with many 
different genes being implicated 
• If one identical twin is affected, the probability of 
the other having the disease is approximately 25% 
• By the end of 2005, 25 genes had been associated 
with asthma in six or more separate populations, 
including GSTM1, IL10, CTLA-4, SPINK5, LTC4S, 
IL4R  and ADAM33, among others 
• Some genetic variants may cause asthma when are 
combined with specific environmental exposures. 
Risk Factors and Etiology                
Medical Conditions   
https://en.wikipedia.org/wiki/Asthma#Causes 
• A triad of atopic eczema, allergic rhinitis and 
asthma is called atopy 
• Asthma has been associated with an autoimmune 
disease,  vasculitis and urticaria 
• There is a correlation between obesity and the risk 
of asthma   
• Medications that can cause problems in asthmatics 
are beta blockers,  angiotensin-converting enzyme 
inhibitors, aspirin, and NSAIDs. 
 
Risk Factors and Etiology                
Exacerbation   
https://en.wikipedia.org/wiki/Asthma#Causes 
• Some individuals will have stable asthma for weeks 
or months and then suddenly develop an episode of 
acute asthma 
• Most individuals can develop severe exacerbation 
from a number of triggering agents (dust, cat and 
dog hair, perfumes, etc.)  
• Viral and bacterial infections of the upper 
respiratory tract can worsen the disease 
• Psychological stress may worsen symptoms. 
 
Risk Factors and Etiology                
Triggers   
http://image.slidesharecdn.com/presentation6-140430130846-phpapp02/95/bronchial-asthma-13-638.jpg?cb=1398952028 
Mechanism   
• The mechanism involves airway inflammation, intermittent 
airflow obstruction, and bronchial hyperresponsiveness 
• Mononuclear cell and eosinophil infiltration, mucus 
hypersecretion, desquamation of the epithelium, smooth 
muscle hyperplasia, and airway remodeling are present 
• Airway hyperresponsiveness or bronchial hyperreactivity is 
an exaggerated response to numerous stimuli  
• The mechanisms include direct stimulation of airway 
smooth muscle and indirect stimulation by 
pharmacologically active substances from mediator-
secreting cells (mast cells, nonmyelinated sensory 
neurons).  
http://emedicine.medscape.com/article/296301-overview#a2 
Mechanism                                           
Airway Inflammation   
• Inflammation may be acute, subacute, or chronic, and the 
presence of airway edema and mucus secretion also 
contributes to airflow obstruction and bronchial reactivity  
• Cells in airway inflammation include mast cells, eosinophils, 
epithelial cells, macrophages, activated T lymphocytes, 
fibroblasts, endothelial cells, atc.  
• Adhesion molecules and cytokine imbalance (e.g., 
selectins, integrin's) are critical in directing the 
inflammatory in the airway 
• The degree of airway hyperresponsiveness correlates with 
the clinical severity of asthma.    
•   
 
 
 
http://emedicine.medscape.com/article/296301-overview#a4 
Mechanism                                             
Mechanism of 
asthma. Antigen 
presentation by 
the dendritic cell 
with the 
lymphocyte and 
cytokine 
response leading 
to airway 
inflammation 
and asthma 
symptoms. 
http://emedicine.medscape.com/article/296301-overview 
Mechanism                                           
Airflow Obstruction   
• Airflow obstruction can be caused by acute 
bronchoconstriction, airway edema, chronic mucous plug 
formation, and airway remodeling  
• Acute bronchoconstriction is the consequence of 
immunoglobulin E-dependent mediator release upon 
exposure to aeroallergens and is the primary component of 
the early asthmatic response  
• Chronic mucous plug formation consists of an exudate of 
serum proteins and cell debris   
•  Airway obstruction causes increased resistance to airflow 
and decreased expiratory flow rates.   
 http://emedicine.medscape.com/article/296301-overview#a4 
Mechanism                                           
Bronchial Hyperresponsiveness   
• Uneven changes in airflow resistance and vasoconstriction 
due to alveolar hypoxia lead to ventilation-perfusion 
mismatch   
• Hyperventilation triggered by the hypoxic drive causes a 
decrease in PaCO2  
•  With worsening obstruction and increasing ventilation-
perfusion mismatch, carbon dioxide retention occurs 
• Later, the increased work of breathing, increased oxygen 
consumption, and increased cardiac output result in 
metabolic acidosis 
• Respiratory failure leads to respiratory acidosis.   
 
 
http://emedicine.medscape.com/article/296301-overview#a4 
Classification  
International Classification of Diseases   
http://apps.who.int/classifications/icd10/browse/2016/en#/J45 
• X Diseases of the respiratory system 
• J45 Asthma 
• J45.0 Predominantly allergic asthma 
• J45.1 Nonallergic asthma 
• J45.8 Mixed asthma 
• J45.9 Asthma, unspecified 
• J46 Status asthmaticus  
Classification                                                
Clinical 
https://en.wikipedia.org/wiki/Asthma#Diagnosis 
Severity 
Symptom 
frequency 
Night time 
symptoms 
 %FEV1 of 
predicted 
FEV1Varia
bility 
SABA use 
Intermittent ≤2/week ≤2/month ≥80% <20% 
≤2 
days/week 
Mild 
persistent 
>2/week 3–4/month ≥80% 20–30% 
>2 
days/week 
Moderate 
persistent 
Daily >1/week 60–80% >30% daily 
Severe 
persistent 
Continuousl
y 
Frequent 
(7×/week) 
<60% >30% ≥twice/day 
Symptoms and Signs   
• Asthma is characterized by recurrent episodes of wheezing, 
shortness of breath, chest tightness, and coughing 
• Sputum may be produced from the lung by coughing but is 
often hard to bring up 
• During recovery from an attack, it may appear pus-like due 
to high levels of white blood cells called eosinophils  
• Symptoms are usually worse at night and in the early 
morning or in response to exercise or cold air 
• Some people with asthma rarely experience symptoms, 
usually in response to triggers, whereas others may have 
marked and persistent symptoms. 
 
https://en.wikipedia.org/wiki/Asthma#Signs_and_symptoms 
Clinical Manifestations                       
Intermittent Asthma   
• Symptoms (difficulty breathing, wheezing, chest tightness, 
and coughing): 
– Occur on fewer than 2 days a week  
– Do not interfere with normal activities  
• Nighttime symptoms occur on fewer than 2 days a month   
• Lung function tests (spirometry and peak expiratory 
flow[PEF]) are normal when the person is not having an 
asthma attack (the results of these tests are 80% or more 
of the expected value and vary little (PEF varies less than 
20%) from morning to afternoon). 
 
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview 
Clinical Manifestations                        
Mild persistent Asthma 
• Symptoms occur on more than 2 days a week but 
do not occur every day  
• Attacks interfere with daily activities  
• Nighttime symptoms occur 3 to 4 times a month  
• Lung function tests are normal when the person is 
not having an asthma attack (the results of these 
tests are 80% or more of the expected value and 
may vary a small amount (PEF varies 20% to 30%) 
from morning to afternoon). 
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview 
Clinical Manifestations                        
Moderate persistent Asthma 
• Symptoms occur daily, inhaled short-acting asthma 
medication is used every day  
• Symptoms interfere with daily activities  
• Nighttime symptoms occur more than 1 time a 
week, but do not happen every day  
• Lung function tests are abnormal (more than 60% 
to less than 80% of the expected value), and PEF 
varies more than 30% from morning to afternoon. 
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview 
Clinical Manifestations                        
Severe persistent Asthma 
• Symptoms: 
• Occur throughout each day  
• Severely limit daily physical activities  
• Nighttime symptoms occur often, sometimes every 
night  
• Lung function tests are abnormal (60% or less of 
expected value), and PEF varies more than 30% 
from morning to afternoon. 
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview 
Clinical Manifestations                        
History   
• Whether symptoms are attributable to asthma 
• Asthma severity 
• Possible precipitating factors 
• Family history (asthma, allergy, sinusitis, rhinitis, 
eczema, nasal polyps) 
• The social history (home and workplace, smoking, 
education, employment, social support, etc) 
• The patient’s exacerbation history   
• The patient’s perception of asthma. 
•   http://emedicine.medscape.com/article/296301-clinical 
Clinical Manifestations                          
an Acute Episode  
• Mild episode: patients may be breathless after physical 
activity, can talk in sentences and lie down, RR is increased,  
accessory muscles of respiration are not used; HR < 100 
bpm; end-expiratory wheezing; oxyhemoglobin saturation 
(OS) is >95%  
• Moderately severe episode: RR is increased; accessory 
muscles of respiration are used; HR is 100-120 bpm; loud 
expiratory wheezing; OS is 91-95% 
• Severe episode: patients are breathless during rest, sit 
upright, talk in words rather than sentences, are agitated; 
RR >30 1/m; accessory muscles of respiration are used, HR 
is >120 bpm; expiratory and inspiratory wheezing; OS <91%.  
 
http://emedicine.medscape.com/article/296301-clinical#b3 
Complications   
https://www.welcomecure.com/diseases/bronchial-asthma/complications 
• Status asthmaticus if obstruction remains for days and 
weeks and fails to respond to treatment  
• Pneumonia or infection in the lungs by bacteria or viruses  
• Atelectasis or collapse of a section of the lung can happen 
if there is excessive mucosal blockage in a smaller airway   
• Respiratory failure, where the levels of oxygen in the blood 
become dangerously low, or the levels of carbon dioxide 
become dangerously high  
• Absenteeism from workplace  
• Anxiety, Depression.   
 
Diagnosis   
• The classical symptoms (wheezing, breathlessness, cough, 
and chest tightness) tend to be variable, seasonal, 
recurrent and/or nocturnal 
• Presence of atopy, family history of asthma in a first degree 
relative, and/or symptomatic worsening after exposure to 
non-specific triggers support a diagnosis of asthma  
• The presence of expiratory polyphonic wheeze is a typical 
finding, and hyperinflated chest may suggest long-standing 
disease 
• Tachycardia, tachypnea, use of accessory muscles of 
respiration suggest an asthma exacerbation.  
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
Diagnosis                                     
Recommendations 
• A clinical diagnosis of asthma should be suspected 
in the presence of recurrent/episodic wheezing, 
breathlessness, cough, and/or chest tightness with 
no alternative explanation for these symptoms  
• None of the symptoms and signs are specific for 
asthma  
• Absence of signs and symptoms at the time of 
presentation does not rule out the presence of 
asthma. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
Diagnosis                                             
Spirometry  1  
https://en.wikipedia.org/wiki/Asthma#Diagnosis 
• If the FEV1 improves >12% following administration of 
a bronchodilator, this is supportive of the diagnosis 
• It however may be normal in those with a history of mild 
asthma, not currently acting up 
• As caffeine is a bronchodilator in people with asthma, the 
use of caffeine before a lung function test may interfere 
with the results  
• Single-breath diffusing capacity can help differentiate 
asthma from COPD 
• It is reasonable to perform spirometry every one or two 
years to follow how well a person's asthma is controlled. 
 
Diagnosis                                             
Spirometry   
http://image.slidesharecdn.com/copyofslsqasthmamanagementpptv050811piccomp-141113083910-conversion-gate02/95/spirometry-basics-2-69-638.jpg?cb=1415868230 
Diagnosis                                             
Spirometry   
http://uninursety.com/images/courses/asthma_05.gif 
Diagnosis                                              
Chest Radiography  
• A chest radiograph may be warranted when 
additional complications like allergic 
bronchopulmonary aspergillosis, or an alternative 
diagnosis like tuberculosis, are under consideration 
• Presence of increased bronchovascular markings 
and low diaphragm are few features noted in 
asthmatics more commonly than normal 
individuals; however, these do not differentiate 
asthma from other pulmonary disorders. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
Diagnosis                                             
Imaging Studies    
http://emedicine.medscape.com/article/296301-differential ncbi.nlm.nih.gov/pmc/articles/PMC4405919/ 
• CT, single-photon emission 
computerized tomography and 
positron emission tomography 
are being investigated to 
understand the 
pathophysiologic and anatomic 
abnormalities in asthmatics 
• They have no role in the 
routine diagnosis of asthma. 
Asthma. Recurrent left 
lower lobe pneumonia. 
Mucoepidermoid 
carcinoma.   
Diagnosis                                              
Differentiation       
http://emedicine.medscape.com/article/296301-differential 
• Alpha1-Antitrypsin 
Deficiency 
• Aspergillosis 
• Bronchiectasis 
• Bronchiolitis 
• COPD 
• Chronic Sinusitis 
• Eosinophilic 
Granulomatosis with 
Polyangiitis  
• Cystic Fibrosis 
 
• Foreign Body Aspiration 
• Gastroesophageal Reflux Disease 
• Heart Failure 
• Pediatric Airway Foreign Body 
• Pediatric Tracheomalacia 
• Pulmonary Embolism 
• Pulmonary Eosinophilia 
• Sarcoidosis 
• Upper Respiratory Tract Infection 
• Vocal Cord Dysfunction 
 
 
 
USMLE TEST 
In which of the following pathological states would the 
oxygen content of the trachea resemble the oxygen content in 
the affected alveoli?   
1.  Emphysema  
2.  Pulmonary fibrosis  
3.  Pulmonary embolism  
4.  Foreign body obstruction distal to the trachea  
5.  Exercise.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
The correct answer is 3: Pulmonary embolism (PE) effectively 
results in a blockage of flow in a vessel to its corresponding 
alveoli. As a result, there is no extraction of oxygen or 
ventilation in this region (i.e. dead space physiology) and the 
alveoli have a gas composition similar to the trachea 
(PAO2=150, PACO2=0). 
Incorrect answers: 1: Emphysema is a diffuse process and does 
not change the oxygen content of an affected alveoli, 2: 
Pulmonary fibrosis reduces the number of functioning alveoli, 
4: An airway foreign body would reduce the oxygen content 
of the affected alveoli, and would result in shunt physiology of 
the alveoli distal to the obstruction, 5: Exercise does not 
significantly change the oxygen content of the alveoli. 
Management                                    
Approach Considerations   
• Treatment of acute asthmatic episodes and control of 
chronic symptoms  
• Pharmacologic management: inhaled corticosteroids, long-
acting bronchodilators, theophylline, leukotriene modifiers, 
anti-immunoglobulin E (IgE) antibodies (omalizumab) and 
anti-IL-5 antibodies in selected patients  
• Relief medications (bronchodilators, systemic 
corticosteroids, and ipratropium) 
• The ultimate goal is to prevent symptoms, minimize 
morbidity from acute episodes, and prevent functional and 
psychological morbidity to provide a healthy (or near 
healthy) lifestyle.  
 
http://emedicine.medscape.com/article/296301-treatment#d1 
Management                                         
The Stepwise Approach to Asthma Therapy  
http://www.ajmc.com/journals/supplement/2005/2005-11-vol11-n14suppl/nov05-2212ps416-s421 
Management                                    
Environmental Control    
• Efforts should focus on the home, patients should clean and 
dust their homes regularly 
• If a patient cannot avoid vacuuming, he or she should use a 
face mask or a double-bagged vacuum with a high-
efficiency particulate air filter 
• If possible, consideration can be given to moving to a higher 
floor in the house or different neighborhood  
• Active smoking and exposure to passive smoke must be 
avoided  
• Air pollution caused by traffic may increase the risk of 
asthma and wheezing.  
 http://emedicine.medscape.com/article/296301-treatment#d9 
Management                                     
Allergen Immunotherapy 
• Immunotherapy be considered if a relationship is 
clear between symptoms and exposure to an 
unavoidable allergen to which the patient is 
sensitive; symptoms occur all year or during a major 
portion of the year; symptoms are difficult to 
control with pharmacologic management because 
the medication is ineffective, multiple medications 
are required, or the patient is not accepting of 
medication. 
http://emedicine.medscape.com/article/296301-treatment#d10 
Management                                     
Monoclonal Antibody Therapy   
• Omalizumab (a humanized murine IgG antibody against the 
Fc component of the IgE antibody) was approved in 2003 
for patients ≥12 y with moderate-to-severe persistent  
• Mepolizumab  (a humanized IgG1 kappa monoclonal 
antibody specific for interleukin 5)  is indicated for add-on 
maintenance treatment of patients ≥ 12 y with severe 
asthma with an eosinophilic phenotype  
• Reslizumab  (an IgG kappa monoclonal antibody that 
inhibits IL-5) is indicated for add-on maintenance treatment 
of patients with severe asthma aged 18 years and older with 
an eosinophilic phenotype. It is administered as an 
intravenous infusion every 4 weeks.  
 
http://emedicine.medscape.com/article/296301-treatment#d11 
Management                                       
Fast–acting Medications   
• Short-acting beta2-adrenoceptor agonists (SABA), such 
as salbutamol are the first line treatment for asthma 
• Anticholinergic medications, such as ipratropium bromide, 
provide additional benefit when used in combination with 
SABA in those with moderate or severe symptoms; they can 
also be used if a person cannot tolerate a SABA   
• Older, less selective adrenergic agonists, such as 
inhaled epinephrine, have similar efficacy to SABAs; they 
are however not recommended due to concerns regarding 
excessive cardiac stimulation. 
 
https://en.wikipedia.org/wiki/Asthma#Diagnosis 
Management                                       
Long–term Control   
• Corticosteroids are the most effective treatment 
• Inhaled forms are usually used except in the case of severe 
persistent disease    
• Inhaled corticosteroids carries a minor risk of adverse 
effects (cataracts, a mild regression in stature)  
• Long-acting beta-adrenoceptor agonists (LABA) can 
improve asthma control, at least in adults  
• Leukotriene receptor antagonists (montelukast and 
zafirlukast) may be used in addition to inhaled 
corticosteroids, typically also in conjunction with a LABA 
• 5-LOX inhibitors may be used as an alternative in the 
chronic treatment of mild to moderate asthma. 
 
https://en.wikipedia.org/wiki/Asthma#Diagnosis 
Management                                        
Nebulizers and Spacers 
Nebulizer 
https://en.wikipedia.org/wiki/Asthma#Diagnosis.wisegeek.com/dry-powder-inhaler.jpg apqualitycare.com/product/nebulizers-spacers/ 
Spacer 
Medications are typically provided as metered-dose 
inhalers (MDIs) in combination with an asthma spacer or as 
a dry powder inhaler.  A nebulizer may also be used. 
Nebulizers and spacers are equally effective in those with 
mild to moderate symptoms.  
Dry powder inhaler 
Management                                        
Emergency Management    
• Oxygen to alleviate hypoxia if saturations fall below 92% 
• Corticosteroid by mouth are recommended with five days 
of prednisone being the same 2 days of dexamethasone  
• Magnesium sulfate intravenous treatment increases 
bronchodilation in moderate severe acute asthma attacks   
• Heliox, a mixture of helium and oxygen, may also be 
considered in severe unresponsive cases  
• The dissociative anesthetic ketamine is theoretically useful 
if intubation and mechanical ventilation is needed in people 
who are approaching respiratory arrest; however, there is 
no evidence from clinical trials to support this.  
 https://en.wikipedia.org/wiki/Asthma#Diagnosis 
Management                                     
Patient Education   
• All members of the healthcare team, including nurses, 
pharmacists, and respiratory therapists, should provide 
education  
• Clinicians should teach patients asthma self-management 
based on basic asthma facts, self-monitoring techniques, 
the role of medications, inhaler use, and environmental 
control measures  
• Treatment goals should be developed for the patient and 
family  
• A written, individualized, daily self-management plan 
should be developed.  
•   http://emedicine.medscape.com/article/296301-overview#a8 
Prognosis   
 
• International asthma mortality is reported as high as 0.86 
deaths per 100,000 persons in some countries 
• Mortality is primarily related to lung function,  but it has 
also been linked with asthma management failure  
• The estimate of lost work and school time from asthma is 
approximately 100 million days of restricted activity 
• Approximately 500,000 annual hospitalizations (40.6% in 
individuals aged 18 y or younger) are due to asthma  
• Patients with poorly controlled asthma develop long-term 
changes over time (i.e., with airway remodeling).   
 
http://emedicine.medscape.com/article/296301-overview#a7 
Prophylaxis   
• Cover bedding with allergy-proof casings   
• Remove carpets from bedrooms and vacuum regularly  
• Use unscented detergents and cleaning materials 
• Keep humidity levels low and fix leaks to reduce the growth 
of organisms such as mold  
• Keep the house clean and keep food in containers   
• If someone is allergic to an animal that cannot be removed 
from the home, the animal should be kept out of the 
bedroom  
• Eliminate tobacco smoke from the home    
• Avoid air pollution, industrial dust, and irritating fumes as 
much as possible. 
 
https://medlineplus.gov/ency/article/000141.htm 
Abbreviations  
COPD - Chronic Obstructive Pulmonary Disease 
EF - peak expiratory flow  
FEV1  - forced expiratory volume in 1 second 
ILO - inducible laryngeal obstruction  
HR - heart rate  
LABA - long-acting beta-adrenoceptor agonists 
OS - oxyhemoglobin saturation  
RR - respiratory rate  
SABA - short-acting beta2-adrenoceptor agonists.  
Diagnostic and treatment guidelines 
Global Initiative for Asthma - Global Initiative for Asthma - GINA 
Asthma Treatment & Management 
Guidelines for diagnosis and management of bronchial asthma: Joint 
ICS/NCCP (I) recommendations 
International ERS/ATS Guidelines on Definition, Evaluation and 
Treatment of Severe Asthma 
BTS/SIGN British guideline on the management of asthma 
Asthma 
